Enhanced Patient Safety; Superior Technical Design - Glaucoma SLT
Pioneer of SLT Technology
Open-angle glaucoma threatens the sight of more than 50 million people worldwide, with the number of annual cases significantly on the rise. This means glaucoma patients are an increasingly important part of any practice. Lumenis offers an array of ophthalmic laser systems that continue to provide the ophthalmologist with essential surgical tools to help lower intraocular pressure and control this progressive, degenerative disease.


A minimally invasive technological breakthrough, the Selecta Family of laser system is changing the future vision of glaucoma patients with Selective Laser Trabeculoplasty (SLT). SLT provides the benefits of Argon Laser Trabeculoplasty (ALT) without the coagulative damage that leads to scarring.
Lumenis’ family of advanced glaucoma lasers is invaluable mainstay in the treatment of glaucoma.





(1064nm @ 3ns) -Cutting
a hole in the iris. “YAG” 


(1064nm @ 3ns)
-Cutting of the capsule.

(532nm @ 3ns) 
-selectively targets
cells in the TM. “SLT” 

Coagulation (PC)
(532nm @ Ms to sec)
the RPE layer 
Addressing Laser Systems

  Angle Closure Glaucoma 
“pupillary block”

  Posterior Capsular Haze “Secondary Cataract”

  Open Angle Glaucoma “High I.O.P"

  Diabetic Retinopathy Macular Edema Retinal Tears, etc. “leaky vessels
or new blood vessels”

Aura PT “YAG”    Yes    Yes        
Selecta® II “SLT”            Yes    
Selecta® Duet “YAG & SLT”    Yes    Yes    Yes    
Selecta® Trio + (Novus Spectra)
“YAG & SLT” + PC
   Yes    Yes    Yes    Yes

Features & Benefits of SLT

PB-2006798 Rev A


Get more info
Useful Links

Lumenis Partner Zone